DH
Highly rated in
17
conditions
Highly rated in
17
conditions
Check Dr. Daniel O. Herzig's experience treating your condition:
About Dr. Daniel O. Herzig

Daniel Herzig is a Colorectal Surgeon and a General Surgeon in Portland, Oregon. Herzig has been practicing medicine for over 23 years and is highly rated in 17 conditions, according to our data. His top areas of expertise are Colorectal Cancer, Anal Cancer, Familial Colorectal Cancer, and Gastroesophageal Junction Cancer. He is licensed to treat patients in Oregon. Herzig is currently accepting new patients.

His clinical research consists of co-authoring 52 peer reviewed articles and participating in 1 clinical trial in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Daniel O. Herzig it is best to call his office and ask if your insurance is accepted.

Accepts Medicare

Dr. Daniel O. Herzig accepts the following insurance:

  •  Ambetter
  •  PacificSource
  •  Regence
  •  Moda Health
  •  Kaiser
  •  BridgeSpan

Call to see if your plan is accepted.
Locations
3303 Sw Bond Ave, Portland, OR 97239
Other Locations
3303 Sw Bond Ave, Portland, OR 97239
Background & Education
Graduate Institution
Vanderbilt University School Of Medicine, 1999.0
Specialties
Colorectal Surgery
General Surgery
Licenses
Surgery in OR
Hospital Affiliations
Mid-Columbia Medical Center
West Valley Hospital
Salem Hospital
OHSU Hospital - Portland
PeaceHealth Southwest Medical Center
Asante Rogue Regional Medical Center
Languages Spoken
English
Gender
Male
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


1 Clinical Trials

A Minimal-Risk, Multi-Center, Prospective, Clinical Trial to Evaluate the PrevisEA Device for Predicting Gastrointestinal Impairment
52 Total Publications

Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.
Summary: Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors